HUMAN-FRATERNITY-MEETING
8.5.2020 17:44:11 CEST | Business Wire | Press release
The Higher Committee of Human Fraternity (HCHF), called on religious leaders and faithful around the world to a day of fasting, prayers and supplications for the good of all humanity on Thursday, May 14 for an end to the novel coronavirus (COVID-19) pandemic.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200508005369/en/
The call is part of the Committee’s (HCHF) efforts to realize the objectives of the Document on Human Fraternity. It invites people around the world to lay all their differences aside and come together and assume their responsibilities against this virus, the first and true enemy of humanity in this era.
Judge Mohamed Abdel Salam , Secretary-General of the Committee (HCHF) said: “The overwhelming response with this call for prayer from leaders and peoples around the world is a true testament to human solidarity and grants us hope in achieving global unity based on human fraternity principles for the safety, security and health of all mankind.”
He also noted that seeing all believers come together in prayers and supplications for an end to this pandemic is dream come true of a universal human unity, which is much needed now more than ever. “We will implore God Almighty for his grace and mercy and trust that He will respond to the hopes of millions of faithful asking to be saved from this deadly pandemic,” he continued.
US-based Rabbi M. Bruce Lustig, Senior Rabbi at Washington Hebrew Congregation and member of the Committee (HCHF) added: “Just as all of us have seen how the global pandemic has taken lives and livelihoods, we have also witnessed it reveal some of the best qualities in humankind.”
Monsignor Yoannis Lahzi Gaid, Personal Secretary of His Holiness Pope Francis and member of the Committee (HCHF), said: “As we await a cure that would spare humanity from this deadly pandemic, our only hope is that God Almighty will save the millions suffering around the world, and help scientists and researchers to succeed in finding the eagerly-awaited cure.”
The Committee (HCHF) seeks to bring humanity together in prayer on Thursday, May 14, in what will be the largest gathering of humanity for one goal. The event will be accompanied by unprecedented media coverage, through the Committee’s social media accounts with hashtag #PrayForHumanity to allow people to interact and share their videos, photos and posts.
The Committee (HCHF) is an independent body of religious leaders, educational scholars and cultural figures from across the world, dedicated to achieving the noble goals of the Document on Human Fraternity signed by Pope Francis and Sheikh Ahmed el-Tayeb, Grand Imam of Al-Azhar, during the Pope’s Apostolic Journey to the United Arab Emirates in February 2019, under the patronage of H.H Sheikh Mohammed Bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20200508005369/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom